Drugmaker Gilead Sciences Inc named Roche Holding AG executive Daniel O’Day as its new chief executive officer, the companies said on Monday.
Source:: Reuters – Business News
Drugmaker Gilead Sciences Inc named Roche Holding AG executive Daniel O’Day as its new chief executive officer, the companies said on Monday.
Source:: Reuters – Business News
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.